Zhi-Xiang Shen

Dissection of mechanisms of Chinese medicinal formula Realgar- <i>Indigo naturalis</i> as an effective treatment for promyelocytic leukemia

Lan Wang, Guang‐Biao Zhou, Ping Liu et al. · Proceedings of the National Academy of Sciences · 2008 · 736 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Jörge E. Cortes, Hagop M. Kantarjian, Tim H. Brümmendorf et al. · Blood · 2011 · 461 citations

Life Sciences, Hematology, Oncology +9

Long-term efficacy and safety of <i>all-trans</i> retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

Jiong Hu, Yuan-Fang Liu, Chuan-Feng Wu et al. · Proceedings of the National Academy of Sciences · 2009 · 438 citations

Medicine, Hematology, Oncology +13

Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial

Jörge E. Cortes, Cármino Antônio De Souza, Manuel Ayala et al. · The Lancet Haematology · 2016 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways

Xiao-Xing Jiang, Qiu-Sheng Chen, Wen-Yu Shi et al. · Experimental Hematology · 2010 · 39 citations

Life Sciences, Cancer Biology, Oncology +15